IPO - Check IPO Date, Price, Lot Size

Akums Drugs & Pharmaceuticals Ltd IPO

Bulkcorp International Limited is a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. The Company is also engaged in the sale of branded pharmaceutical formulations and manufacturing of active pharmaceutical ingredients. Some of its other services include formulation research and development, preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. Some of its manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

Akums Drugs & Pharmaceuticals Ltd IPO Details

Total Shares Offered

₹ 2,73,45,163

Offer to Public

1,73,30,435

Retail Max (Shares)

₹ 27,12,425

Pre Issue Promoters Holding

₹ 12,14,65,630

Exchange

BSE

Issue size

₹ 1856.74 Cr

IPO Open Date

Jul 30, 2024

Close Date

Aug 1, 2024

Lot Size

Min Investment

₹ 14,212

Issue Type

Book Building

Listing Date

Aug 6, 2024

Akums Drugs & Pharmaceuticals Ltd IPO Dates

Jul 30, 2024

Opening date

Aug 1, 2024

Closing date

Aug 2, 2024

Basis of Allotment

Aug 5, 2024

Initiation of Refunds

Aug 5, 2024

Credit of Shares

Aug 6, 2024

Listing date

Details

Sector	Type
Sector	Pharmaceuticals - Indian - Bulk Drugs & Formln
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*
QIB	0x	20343188
NII	0x	4068637
Retail	0x	2712425
Employee	0x	220913
Total	0x	27345163

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

20343188

4068637

2712425

220913

27345163

Akums Drugs & Pharmaceuticals Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	4,118.16	4,178.18	3,654.82
EBITDA	286.93	-37.55	210.32
PAT	161.00	-165.45	125.43
Total Assets	853.92	551.85	524.22
Share Capital	30.62	28.61	28.61
Total Borrowings	93.91	309.33	207.71
Operating Activities (Net Cash)	200.55	-132.76	155.43
Investing Activities (Net Cash)	309.27	130.27	122.91
Financing Activities (Net Cash)	93.91	309.33	207.71
Net Cashflow	356.12	73.31	8.85

About Akums Drugs & Pharmaceuticals Ltd

The Company was incorporated as a public company, limited by shares, under the Companies Act, 1956, as amended, in the name of `Akums Drugs and Pharmaceuticals Limited', pursuant to a certificate of incorporation dated April 19, 2004 issued by the Registrar of Companies, Delhi and Haryana in New Delhi (RoC). The Company received a certificate of commencement of business issued by the RoC dated May 13, 2004.

The pharmaceutical industry in India is characterized by significant challenges, including, high capital expenditure required to establish and maintain sizeable manufacturing units, research and development expertise, trained manpower, consistent quality control, pricing pressure, disruptions within the supply chain, and the long-drawn regulatory and client approval and inspection processes, among others. An increase in chronic patient population, insurance penetration, trade generics, demand from tier II and III cities, and Government schemes focused on drug access are supporting growth in the Indian pharmaceutical market. Contract Development and Manufacturing Organizations assist pharmaceutical companies to employ an asset-light model and access global and specialized expertise while staying abreast with rapid innovation launches.

Peer Comparison:

Divi's Laboratories Ltd
Suven Pharmaceuticals Ltd
Gland Pharma Ltd
Torrent Pharmaceuticals Ltd
Alkem Laboratories Ltd
ERIS Lifesciences Ltd
J B Chemicals & Pharmaceuticals Ltd
Mankind Pharma Ltd
Innova Captab Ltd

Akums Drugs & Pharmaceuticals Ltd Key Points

Strengths

Largest India-focused CDMO serving the Indian domestic pharmaceutical industry.

Diverse client base with longstanding CDMO relationships.

Large and rapidly growing R&D capabilities across its product portfolio.

Strategic presence across the pharmaceutical value chain.

Experienced and entrepreneurial management team with a proven track record and marquee healthcare focused PE investor.

Risk

Its manufacturing units and research and development centres are concentrated in Haridwar, Uttarakhand and the company is exposed to risks originating from economic, regulatory, political and other changes in this region, including natural disasters, which could adversely affect its business, results of operations and financial condition.

Any slowdown or shutdown in its manufacturing and research and development operations could have an adverse effect on its business, results of operations, financial condition and cash flows.

Any manufacturing or quality control concerns or its inability to deliver products on a timely basis, or at all, could result in the cancellation of purchase orders, breaches of relevant agreements, and termination of agreements by its clients and distributors, which could have an adverse effect on its business, results of operations, financial condition and cash flows.

Strategy

Leverage its leadership position to continue to increase its market share and consolidate its position in the CDMO market.

Sustaining R&D for product development across therapies and dosage forms.

Grow its domestic formulations business.

Expanding its global presence through strategic initiatives.

Scale its API business.

How To Apply for Akums Drugs & Pharmaceuticals Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Akums Drugs & Pharmaceuticals Ltd IPO?

Akums Drugs & Pharmaceuticals Ltd's IPO offers shares for up to 680 It begins on Jul 30, 2024 and ends on Aug 1, 2024.

What is the price of the Akums Drugs & Pharmaceuticals Ltd IPO?

The price of Akums Drugs & Pharmaceuticals Ltd IPO ranges between ₹646 to ₹679 per share.

What are the open and close dates for the Akums Drugs & Pharmaceuticals Ltd IPO?

The Akums Drugs & Pharmaceuticals Ltd IPO opens on Jul 30, 2024 and closes on Aug 1, 2024.

When will the Akums Drugs & Pharmaceuticals Ltd IPO be allotted?

The allotment for the Akums Drugs & Pharmaceuticals Ltd IPO will be finalised on Aug 2, 2024. The shares will be listed on BSE and NSE on Aug 6, 2024.

What is the minimum lot size required for Akums Drugs & Pharmaceuticals Ltd IPO?

The minimum lot size for Akums Drugs & Pharmaceuticals Ltd IPO is 22 shares, priced between ₹646 to ₹679 per share.

What is the GMP of Akums Drugs & Pharmaceuticals Ltd IPO?

The GMP (Grey Market Premium) of Akums Drugs & Pharmaceuticals Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Akums Drugs & Pharmaceuticals Ltd IPO?

To check the allotment status of Akums Drugs & Pharmaceuticals Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Akums Drugs & Pharmaceuticals Ltd IPO getting listed?

The Akums Drugs & Pharmaceuticals Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Jul 30, 2024, and closes on Aug 1, 2024. The allotment is finalised on Aug 2, 2024.

How do you apply for the Akums Drugs & Pharmaceuticals Ltd IPO?

To apply for the Akums Drugs & Pharmaceuticals Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.